PT Central Proteina Prima Tbk (IDX:CPRO)

IDX:CPRO Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	423,655	319,976	401,468	373,668	2,211,700
Depreciation & Amortization	157,393	151,152	147,887	132,783	164,013
Other Operating Activities	-211,335	294,575	-225,870	-222,241	-2,276,504
Operating Cash Flow	369,713	765,703	323,485	284,210	99,209
Operating Cash Flow Growth	-51.72%	136.70%	13.82%	186.48%	-86.89%
Capital Expenditures	-228,029	-203,752	-117,158	-163,461	-141,807
Sale of Property, Plant & Equipment	1,136	345	1,232	1,147	5,420
Sale (Purchase) of Real Estate	-	-	-	-2,094	-30,486
Investing Cash Flow	-226,893	-203,407	-115,926	-164,408	-166,873
Short-Term Debt Issued	188,324	-	195,241	-	-
Long-Term Debt Issued	3,812	49,534	34,880	487,292	116,134
Total Debt Issued	192,136	49,534	230,121	487,292	116,134
Short-Term Debt Repaid	-	-12,370	-	-172,569	-50,883
Long-Term Debt Repaid	-293,171	-568,503	-480,831	-433,505	-197,803
Total Debt Repaid	-293,171	-580,873	-480,831	-606,074	-248,686
Net Debt Issued (Repaid)	-101,035	-531,339	-250,710	-118,782	-132,552
Common Dividends Paid	-	-	-	-	-670
Other Financing Activities	-6,220	-7,243	41,259	-29,300	-3,192
Financing Cash Flow	-107,255	-538,582	-209,451	-148,082	-136,414
Foreign Exchange Rate Adjustments	601	734	-1,129	8,043	596
Net Cash Flow	36,166	24,448	-3,021	-20,237	-203,482
Free Cash Flow	141,684	561,951	206,327	120,749	-42,598
Free Cash Flow Growth	-74.79%	172.36%	70.87%	-	-
Free Cash Flow Margin	1.42%	6.05%	2.29%	1.47%	-0.53%
Free Cash Flow Per Share	2.38	9.43	3.46	2.03	-0.71
Cash Interest Paid	149,399	151,471	171,070	197,435	190,651
Cash Income Tax Paid	119,833	105,558	78,772	107,964	51,635
Levered Free Cash Flow	48,524	417,087	142,362	-3,693	-622,439
Unlevered Free Cash Flow	142,119	531,805	266,160	132,838	-480,374

Source: S&P Global Market Intelligence. Standard template. Financial Sources.